These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 31788105)

  • 1. Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients.
    Huszno J; Kolosza Z
    Oncol Lett; 2019 Dec; 18(6):6275-6283. PubMed ID: 31788105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of the Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios in Male Breast Cancer Patients.
    Huszno J; Kołosza Z; Mrochem-Kwarciak J; Zajusz A
    Oncology; 2020; 98(7):487-492. PubMed ID: 32344419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
    Leng J; Wu F; Zhang L
    Front Oncol; 2022; 12():734948. PubMed ID: 35651788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
    Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
    Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLR, MLR, and PLR are adverse prognostic variables for sleeve lobectomy within non-small cell lung cancer.
    Han R; Zhang F; Hong Q; Visar D; Zhan C; Zhao C; Wang F; Zhang S; Li F; Li J; Mu J
    Thorac Cancer; 2024 Aug; 15(24):1792-1804. PubMed ID: 39034535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
    Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
    Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study.
    Guo L; Ren H; Pu L; Zhu X; Liu Y; Ma X
    Cancer Manag Res; 2020; 12():7173-7188. PubMed ID: 33061563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high monocyte-to-lymphocyte ratio predicts poor prognosis in patients with radical cystectomy for bladder cancer.
    Shi H; Wang K; Yuan J; Mao W; Wu Z; Liu Q; Xie J; Peng B
    Transl Cancer Res; 2020 Sep; 9(9):5255-5267. PubMed ID: 35117892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between platelet-to-lymphocyte ratio and outcomes in HER2-positive advanced breast cancer patients treated with pyrotinib: a retrospective study.
    Hao L; Dong J; Yu H; Chen J; Han X; Pan Y
    Transl Cancer Res; 2023 Oct; 12(10):2726-2741. PubMed ID: 37969380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.
    Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB
    Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio and platelets in prognosis of patients with prostate cancer.
    Huszno J; Kołosza Z; Mrochem-Kwarciak J; Telka E; Jochymek B; Miszczyk L
    Oncol Lett; 2022 Sep; 24(3):305. PubMed ID: 35949621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)-A Retrospective Single Center Study and a Literature Review.
    Mireștean CC; Stan MC; Iancu RI; Iancu DPT; Bădulescu F
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
    Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
    Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?
    Solmaz S; Uzun O; Acar C; Sevindik OG; Piskin O; Ozsan HG; Demirkan F; Undar B; Alacacioglu A; Ozcan MA; Alacacioglu I
    J Lab Physicians; 2018; 10(4):363-369. PubMed ID: 30498304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer.
    Liu C; Huang Z; Wang Q; Sun B; Ding L; Meng X; Wu S
    Onco Targets Ther; 2016; 9():4653-60. PubMed ID: 27536129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients.
    Jakubowska K; Koda M; Grudzińska M; Kańczuga-Koda L; Famulski W
    World J Gastroenterol; 2020 Aug; 26(31):4639-4655. PubMed ID: 32884222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.